Corvus Pharmaceuticals Inc (CRVS)
2.16
+0.05
(+2.37%)
USD |
NASDAQ |
May 31, 16:00
2.15
-0.01
(-0.46%)
After-Hours: 20:00
Corvus Pharmaceuticals Shares Outstanding: 62.55M for May 7, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
May 07, 2024 | 62.55M |
May 06, 2024 | 62.55M |
April 18, 2024 | 49.04M |
March 31, 2024 | 49.04M |
March 19, 2024 | 49.04M |
December 31, 2023 | 49.04M |
November 07, 2023 | 49.04M |
September 30, 2023 | 49.04M |
August 08, 2023 | 48.97M |
June 30, 2023 | 48.90M |
April 18, 2023 | 46.57M |
March 31, 2023 | 46.57M |
March 28, 2023 | 46.57M |
March 27, 2023 | 46.57M |
December 31, 2022 | 46.55M |
November 03, 2022 | 46.55M |
September 30, 2022 | 46.55M |
August 08, 2022 | 46.55M |
June 30, 2022 | 46.55M |
May 05, 2022 | 46.55M |
April 18, 2022 | 46.55M |
March 31, 2022 | 46.55M |
March 10, 2022 | 46.55M |
December 31, 2021 | 46.55M |
November 01, 2021 | 46.55M |
Date | Value |
---|---|
September 30, 2021 | 46.55M |
August 02, 2021 | 42.42M |
June 30, 2021 | 42.42M |
April 29, 2021 | 38.31M |
April 19, 2021 | 38.31M |
March 31, 2021 | 38.31M |
March 25, 2021 | 38.31M |
February 17, 2021 | 37.85M |
December 31, 2020 | 28.37M |
October 29, 2020 | 28.06M |
September 30, 2020 | 28.06M |
July 30, 2020 | 28.04M |
June 30, 2020 | 28.03M |
April 30, 2020 | 27.95M |
April 13, 2020 | 27.95M |
March 31, 2020 | 27.95M |
March 09, 2020 | 29.33M |
January 31, 2020 | 27.95M |
December 31, 2019 | 27.95M |
November 08, 2019 | 27.95M |
October 29, 2019 | 29.41M |
September 30, 2019 | 29.41M |
August 01, 2019 | 29.39M |
June 30, 2019 | 29.35M |
May 09, 2019 | 29.33M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
27.95M
Minimum
Nov 08 2019
62.55M
Maximum
May 06 2024
40.68M
Average
46.55M
Median
Nov 01 2021
Shares Outstanding Benchmarks
Cyclacel Pharmaceuticals Inc | 1.463M |
Enanta Pharmaceuticals Inc | 21.18M |
Oragenics Inc | 4.481M |
Nanoviricides Inc | 11.81M |
MAIA Biotechnology Inc | 21.84M |